Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality

Conclusion
Two independent modelling techniques that have been employed in the oncology literature both suggest a long-term survival benefit associated with inhaled treprostinil treatment in patients with PH-ILD.

Source: Thorax - March 15, 2024 Category: Respiratory Medicine Authors: Nathan, S. D., Johri, S., Joly, J. M., King, C. S., Raina, A., McEvoy, C. A., Lee, D., Shen, E., Smith, P., Deng, C., Waxman, A. B. Tags: Open access, Thorax Interstitial lung disease Source Type: research